Headquarters: Boston, Massachusetts, United States
Total Funding: 210000000.0
Founded Date: 2017-01-01
Employee Number: 11-50
Last Funding Type: Series C
Investors Number: 14.0
Last Funding Date: 2021-11-29
Technology: Anti-infective Drugs
Funding Status: Late Stage Venture
Estimated Revenue: $1M to $10M
Industry: Early Drug Development